PCI Biotech convenes an extraordinary general meeting to propose a fully underwritten Rights Issue of NOK 360 million NewsKristin EivindvikAugust 24, 2018
PCI Biotech initiates research collaboration with Bavarian Nordic NewsKristin EivindvikAugust 20, 2018
Extension of preclinical research collaboration agreement with a top-10 large pharma company NewsKristin EivindvikJune 15, 2018
PCI Biotech Holding ASA will be transferred to Oslo Børs from 27.04.2018 NewsKristin EivindvikApril 27, 2018
Publication of prospectus summary for transfer of listing to Oslo Børs NewsKristin EivindvikApril 25, 2018
Exercise of employee share options and resolution to increase the share capital NewsKristin EivindvikApril 12, 2018
